Actively Recruiting
Therapeutic Effect of Electroacupuncture at Zusanli (ST-36) on Diabetic Foot Wounds
Led by Zhongda Hospital · Updated on 2026-03-19
76
Participants Needed
1
Research Sites
128 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if electroacupuncture at the Zusanli (ST-36) can assist in the treatment of diabetic foot ulcers. The main question it aims to answer is: Can electroacupuncture at the Zusanli (ST-36) promote wound healing in patients with diabetic foot ulcers? Researchers will compare outcomes between participants receiving electroacupuncture plus standard treatment and those receiving standard treatment alone to assess the effect of Zusanli (ST36) stimulation on wound healing in patients with diabetic foot ulcers. Participants will: Receive standard diabetes treatment (including diabetes education, dietary control, insulin combined with oral hypoglycemic agents to manage blood glucose, and effective antibiotics to control infection. For patients with foot ulcers, the wound will be cleaned with saline; abscesses will be drained if present; daily dressing changes.) Participants in the electroacupuncture group will receive electroacupuncture at Zusanli(ST-36) every day; 6 sessions constitute one treatment course, for a total of 4 courses. Visit the hospital for examinations before treatment and after each treatment course to measure the ankle-brachial index (ABI), assess diabetic foot Wagner grade, and evaluate hemodynamic parameters.
CONDITIONS
Official Title
Therapeutic Effect of Electroacupuncture at Zusanli (ST-36) on Diabetic Foot Wounds
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with diabetic foot ulcers
- Classified as blood stasis obstructing the collateral pattern by Traditional Chinese Medicine criteria
- Wagner Grade 1 to 3 ulcers with an area between 2 cm² and 30 cm²
- Male or female aged 18 to 75 years
- Provided signed informed consent and able to comply with study procedures
You will not qualify if you...
- Severe diseases affecting brain, liver, heart, lungs, or kidneys
- Pregnant women or planning pregnancy
- Glycosylated hemoglobin (HbA1c) level of 9% or higher
- Psychiatric disorders
- Genetic or infectious diseases, malignant tumors, or other severe conditions with short life expectancy
- Participation in other clinical trials within 4 weeks before randomization
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zongda Hospital affiliated to Southeast University
Nanjing, Jiangsu, China, 210009
Actively Recruiting
Research Team
D
Dachun Chen
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here